Philip Borden
Labshares
Philip Borden is the CEO of Labshares, a Greater Boston company that gives emerging biotech teams flexible, capital-efficient access to fully-equipped shared lab space — so scientists can focus on their science instead of managing medical waste, freezer alarms, and five-year leases.
Before Labshares, Philip spent more than two decades as a healthcare investor — from Frazier Healthcare Partners in Seattle, to more than a decade as a general partner at Riverside Partners, and later Galen Partners and Longfellow Healthcare Partners. He's a Duke molecular biologist and a Baker Scholar out of Harvard Business School, and his throughline is a conviction that the biggest edge in biotech isn't the flashiest round — it's staying alive. This is a conversation about relationships, capital efficiency, and the unglamorous discipline that actually keeps companies breathing.
